Oramed Pharmaceuticals Inc.
ORMP· Nasdaq
ORMPOramed Pharmaceuticals Inc.
Filed Jan 13, 2016 · 10-Q · 44 days after period end · 0001213900-16-010085
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Net Income | -$2.39M | -$1.90M | -$1.12M | -$958.75K |
| EPS Diluted | $0.21 | $0.19 | $0.14 | $0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR
ended Nov 30, 2015 · filed Jan 13, 2016 · 44 d after period end
